Target intelligence / Profile preview

Lactones and thiolactones

Molecular classification
Chemical class, Functional group, Metabolite class
01

Overview

Lactones and thiolactones are cyclic organic compounds characterized by a closed ring containing an ester or thioester linkage, respectively. They do not represent a single biological target like a receptor or enzyme but are instead a broad class of chemical functional groups found in various drugs and endogenous molecules. In pharmacology, the lactone ring is frequently employed as a prodrug moiety, as seen in HMG-CoA reductase inhibitors like lovastatin, which require hydrolysis to their active hydroxy acid form (PubChem). Endogenously, N-acyl homoserine lactones (AHLs) are critical signaling molecules used by Gram-negative bacteria for quorum sensing to coordinate virulence and biofilm formation (Miller & Bassler, 2001). Thiolactones, such as homocysteine thiolactone, are reactive intermediates in amino acid metabolism that can cause protein damage through N-homocysteinylation, contributing to cardiovascular disease (Jakubowski, 2000). Enzymes known as lactonases, including the paraoxonase (PON) family, are responsible for the hydrolysis and detoxification of these cyclic compounds in humans (Draganov et al., 2005). Because of their diverse roles, they are studied both as structural components of therapeutic agents and as indirect targets for quorum-quenching strategies in infectious diseases. Their biological activity is largely defined by the stability of the cyclic ring and the specificity of the enzymes that catalyze their opening.

Other names
Cyclic estersCyclic thioestersN-acyl homoserine lactonesAHLsHomocysteine thiolactone
02

Mechanism of action

Lactones and thiolactones typically serve as prodrugs or signaling molecules that are activated or deactivated via enzymatic hydrolysis by lactonases or esterases (e.g., PON1), or they act as ligands for bacterial transcription factors like LuxR in quorum sensing (Miller & Bassler, 2001; Draganov et al., 2005).

03

Biological functions

Quorum sensingMetabolic signalingProdrug activationProtein modification
04

Disease associations

Bacterial infectionCardiovascular diseaseAtherosclerosisHyperhomocysteinemia
05

Safety considerations

Hydrolytic instabilityMetabolic activation requirementsProtein homocysteinylationOff-target effects
06

Interacting drugs

Lovastatin

6 more in the full profile.

07

Biomarkers

Paraoxonase 1 (PON1) activityHomocysteine thiolactone levelsN-acyl homoserine lactone concentration

Beyond the preview

Go deeper on Lactones and thiolactones.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lactones and thiolactones.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call